Last Updated on June 4, 2021 by Ithos Global Regulatory Team
Health Canada has released a voluntary questionnaire for the proposed removal of substances from the Revised-In Commerce List (R-ICL).
If the industry does not support use of a substance, Health Canada will remove it from the R-ICL. If a company later wishes to use that substance, it will be treated as a new substance. In order to use it, the raw material supplier or the company wishing to use the substance will have to submit a new expanded information file.
The regulatory team at Ithos Global has checked its Information Network (IIN) list of chemicals that our clients have used that are on the R-ICL and not listed on the Domestic Substances List (DSL), which puts them at risk of removal. We recommend that you check if any of these chemicals are of interest to you. If your company has an interest in any of the substances that Health Canada has proposed for delisting, please contact Ithos Global. We will respond to the Personal Care Products Council (PCPC) by the April 26, 2021 deadline. Ithos Global also has the ability to check formulas already in the IIN. If you need this service, please let us know before April 20th.
If these materials stay on R-ICL, they can continue to be used. If the substance is removed from the R-ICL but is then later used in a formula, the substance will require listing on the DSL. This will occur if and when a certain threshold of use (100 or 1000 kg annually in most cases) is met. The substance would have to be registered on the DSL with the same data requirements and fees required for all new substances.
